OpenAlex
PricingAboutJobs
Log inGet started
Work

Use of ruxolitinib to successfully treat chronic mucocutaneous candidiasis caused by gain-of-function signal transducer and activator of transcription 1 (STAT1) mutation

HTML PDF

Year: 2015
Type: article
Study design: Case Report
Source: Journal of Allergy and Clinical Immunology
DOI: 10.1016/j.jaci.2014.12.1867
Authors: Eleanor Higgins, Tariq Al Shehri, Maeve A. McAleer, Niall Conlon, Conleth Feighery, Desa Lilic, Alan D. Irvine
Institutions: St. James's Hospital, Newcastle University, Children's Health Ireland at Crumlin, National Children’s Research Centre, Trinity College Dublin
Language: English

Topic: Immunodeficiency and Autoimmune Disorders
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: ruxolitinib, chronic mucocutaneous candidiasis, STAT1 gain-of-function mutation, JAK inhibitors, alopecia areata, STING, interferonopathies, genetic immunodeficiency, autoimmunity, cytotoxic T lymphocytes, interferon signaling, interferon-stimulated genes
SDG: Good health and well-being

Open Access status: bronze
OpenAlex ID: W2115044545
FWCI: 9.745
Cites: 11
Cited by: 186
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms